INTRODUCTION The comparative value and suitability of outcome measures are uncertain in chronic inflammatory demyelinating polyneuropathy (CIDP). METHODS We studied 35 patients with CIDP using the Overall Neuropathy Limitation Scale (ONLS), the inflammatory Rasch-built Overall Disability Scale (I-RODS) and the Medical Research Council Sum Score (MRCSS). RESULTS Significant associations were determined between initial deficit and ONLS (p=0.002) and MRCSS improvement (p=0.001), but not I-RODS. A strong inverse correlation was observed between disease duration and I-RODS (p=0.002), but not ONLS/MRCSS improvement. A strong association was observed between age ≤40 years and I-RODS (p=0.001), but not ONLS/MRCSS improvement. Using m...
Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-b...
Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-b...
Introduction/Aims: Treatment response and its timing are variable in chronic inflammatory demyelinat...
INTRODUCTION The comparative value and suitability of outcome measures are uncertain in chronic i...
Introduction: The comparative value and suitability of outcome measures are uncertain in chronic inf...
It is unclear whether frequently used cutoff values for outcome measures defining minimal clinically...
INTRODUCTION The use of outcome measures is recommended for chronic inflammatory demyelinating po...
Outcome measures are recommended in the management of chronic inflammatory demyelinating polyneuropa...
Outcome measures are recommended in the management of chronic inflammatory demyelinating polyneuropa...
We performed responsiveness comparison between the patient-reported Inflammatory Rasch-built Overall...
Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-b...
Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-b...
Introduction/Aims: Treatment response and its timing are variable in chronic inflammatory demyelinat...
INTRODUCTION The comparative value and suitability of outcome measures are uncertain in chronic i...
Introduction: The comparative value and suitability of outcome measures are uncertain in chronic inf...
It is unclear whether frequently used cutoff values for outcome measures defining minimal clinically...
INTRODUCTION The use of outcome measures is recommended for chronic inflammatory demyelinating po...
Outcome measures are recommended in the management of chronic inflammatory demyelinating polyneuropa...
Outcome measures are recommended in the management of chronic inflammatory demyelinating polyneuropa...
We performed responsiveness comparison between the patient-reported Inflammatory Rasch-built Overall...
Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-b...
Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-b...
Introduction/Aims: Treatment response and its timing are variable in chronic inflammatory demyelinat...